2024-03-29T14:03:36Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_908258A77893
2024-03-23T02:41:27Z
serval:BIB_908258A77893
High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel Disease.
10.14309/ajg.0000000000000289
000476563000021
31205131
Pittet
L.F.
author
Verolet
C.M.
author
Michetti
P.
author
Girardin
M.
author
Juillerat
P.
author
Mottet
C.
author
Maillard
M.H.
author
Siegrist
C.A.
author
Posfay-Barbe
K.M.
author
Swiss Inflammatory Bowel Disease Cohort Study Group
contributor
article
2019-07
The American journal of gastroenterology
1572-0241
0002-9270
journal
114
7
1130-1141
Adult
Analysis of Variance
Female
Humans
Immunocompromised Host
Immunomodulation/immunology
Immunosuppressive Agents/therapeutic use
Inflammatory Bowel Diseases/drug therapy
Inflammatory Bowel Diseases/immunology
Linear Models
Male
Middle Aged
Patient Safety
Pneumococcal Infections/prevention & control
Pneumococcal Vaccines/administration & dosage
Pneumococcal Vaccines/immunology
Risk Assessment
Switzerland
Treatment Outcome
Vaccination/methods
Vaccines, Conjugate/administration & dosage
Vaccines, Conjugate/immunology
eng
60_published
peer-reviewed
Publication types: Clinical Trial, Phase IV ; Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
Publication Status: ppublish